Troy Brooks
Physician Assistant · Stanton, KYNPI 1447364898
Payments from drug & device makers
Across 61 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$165
- Abbott$149
- Lilly USA, LLC$139
- Novo Nordisk$124
- Boehringer Ingelheim$76
- GSK$70
- plus $387 from 12 others
What the payments were for
- Food & beverage$1,110100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $165 |
| Abbott | 9 | $149 |
| Lilly USA, LLC | 7 | $139 |
| Novo Nordisk | 7 | $124 |
| Boehringer Ingelheim | 5 | $76 |
| GSK | 4 | $70 |
| AbbVie | 4 | $70 |
| Johnson & Johnson | 4 | $62 |
| Pfizer | 3 | $57 |
| Exact Sciences | 2 | $33 |
| Bayer | 1 | $27 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Corium, LLC | 1 | $24 |
| Shield Therapeutics Inc | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
How this compares
$1,110 in reported general payments places this provider in the 70th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 125 | $138,944 |
| EliquisApixaban | 95 | $101,562 |
| JanuviaSitagliptin Phosphate | 58 | $83,725 |
| JardianceEmpagliflozin | 52 | $61,999 |
| XareltoRivaroxaban | 35 | $49,885 |
| LinzessLinaclotide | 29 | $32,138 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $31,263 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 86 | $24,044 |
| TrulicityDulaglutide | 15 | $18,981 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $16,058 |
| FarxigaDapagliflozin Propanediol | 15 | $15,137 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $13,118 |
| TradjentaLinagliptin | 11 | $9,236 |
| Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm | 12 | $7,414 |
| Humalog Kwikpen U-100Insulin Lispro | 17 | $4,057 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $124 | $138,944125 claims |
| PfizerEliquis | $57 | $101,56295 claims |
| Boehringer IngelheimJardiance, Tradjenta | $76 | $71,23663 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Shingrix | $70 | $51,96872 claims |
| Johnson & JohnsonXarelto | $62 | $49,88535 claims |
| AbbVieLinzess | $70 | $32,13829 claims |
| Lilly USA, LLCTrulicity | $139 | $18,98115 claims |
| AstraZenecaFarxiga, Symbicort | $165 | $18,70526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,448 physician assistant providers in Kentucky.
Other physician assistant in Stanton
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Seth KingBowling Green$91K
- Marty MullinsHazard$63K
- Lauri GarnerVersailles$33K
- Robert TatumLouisville$29K
- Michelle JonesLexington$29K
- Grace IsaacsLouisville$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.